—

Browse

You are looking at 131 - 140 of 4,637 items for

Clear All

Full access

BPI24-020: Institutional Policy Implementation for Allocating Chemotherapy During a Shortage

Full access

BPI24-021: Impact of Social Determinants (SDOH) on Surgery and Patient Outcomes in Early-Stage Non–Small Cell Lung Cancer (eNSCLC)

Full access

BPI24-022: Our Approach to Patient Selection for Polatuzumab-Based Therapy in Advanced Diffuse Large B-Cell Lymphoma

Full access

BPI24-023: Empirical Study to Estimate Real World Impact of Delay in Adjuvant Treatment on Healthcare Resource Utilization and Cost Burden

Full access

BPI24-024: Evaluating and Improving Post-Operative VTE Prophylaxis in Patients With a History of Cancer: Results of a Quality Improvement Initiative in a Community Hospital Setting

Full access

BPI24-025: Prostate Biopsies Against Medical Advice: Unveiling New Biomarker Insights for Men

Full access

BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population

Full access

BPI24-028: A Best Evidence–Based Practice of Management of Pruritus to Anti–PD-1/PD-L1 Therapy

Full access

BPI24-200: Delays in Adjuvant Therapy in Head and Neck Cancers: Identifying Population Disparities and Implementing Solutions

Full access

CGE24-094: Recommendation and Genotyping Discrepancies in DPYD for Oncology Patients

Filter

Share Link

Browse

You are looking at 131 - 140 of 4,637 items for

BPI24-020: Institutional Policy Implementation for Allocating Chemotherapy During a Shortage

BPI24-021: Impact of Social Determinants (SDOH) on Surgery and Patient Outcomes in Early-Stage Non–Small Cell Lung Cancer (eNSCLC)

BPI24-022: Our Approach to Patient Selection for Polatuzumab-Based Therapy in Advanced Diffuse Large B-Cell Lymphoma

BPI24-023: Empirical Study to Estimate Real World Impact of Delay in Adjuvant Treatment on Healthcare Resource Utilization and Cost Burden

BPI24-024: Evaluating and Improving Post-Operative VTE Prophylaxis in Patients With a History of Cancer: Results of a Quality Improvement Initiative in a Community Hospital Setting

BPI24-025: Prostate Biopsies Against Medical Advice: Unveiling New Biomarker Insights for Men

BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population

BPI24-028: A Best Evidence–Based Practice of Management of Pruritus to Anti–PD-1/PD-L1 Therapy

BPI24-200: Delays in Adjuvant Therapy in Head and Neck Cancers: Identifying Population Disparities and Implementing Solutions

CGE24-094: Recommendation and Genotyping Discrepancies in DPYD for Oncology Patients

Filter Filter

Share Link

Browse

You are looking at 131 - 140 of 4,637 items for

BPI24-020: Institutional Policy Implementation for Allocating Chemotherapy During a Shortage

BPI24-021: Impact of Social Determinants (SDOH) on Surgery and Patient Outcomes in Early-Stage Non–Small Cell Lung Cancer (eNSCLC)

BPI24-022: Our Approach to Patient Selection for Polatuzumab-Based Therapy in Advanced Diffuse Large B-Cell Lymphoma

BPI24-023: Empirical Study to Estimate Real World Impact of Delay in Adjuvant Treatment on Healthcare Resource Utilization and Cost Burden

BPI24-024: Evaluating and Improving Post-Operative VTE Prophylaxis in Patients With a History of Cancer: Results of a Quality Improvement Initiative in a Community Hospital Setting

BPI24-025: Prostate Biopsies Against Medical Advice: Unveiling New Biomarker Insights for Men

BPI24-026: Utilization of ExoDx Prostate Test for Prostate Cancer Risk Stratification in the African American Population

BPI24-028: A Best Evidence–Based Practice of Management of Pruritus to Anti–PD-1/PD-L1 Therapy

BPI24-200: Delays in Adjuvant Therapy in Head and Neck Cancers: Identifying Population Disparities and Implementing Solutions

CGE24-094: Recommendation and Genotyping Discrepancies in DPYD for Oncology Patients

Filter